Market Inference - Daily Stock Reports
WEBMarket Inference - Daily Stock Reports. BELFA. Bel Fuse to Acquire Majority Stake in Enercon Technologies for $400 Million. 2024-09-19. TECHNOLOGY. Magnite Successfully Lowers Interest Rate by 75 Basis Points. 2024-09-19. HCWC.
Market Inference: Today's Edition
WEBMerit Medical Acquires Cook Medical's Lead Management Portfolio. Market Inference combines deep investment knowledge, big data, and state of the art machine learning tools to create institutional quality stock reporting and investment analysis.
Daily Stock Reports - Market Inference
WEBEli Lilly to Acquire Morphic for $3.2 Billion | 2024-07-08 | PHARMACEUTICAL. Vista Outdoor Increases Acquisition Price to $2.1 Billion | 2024-07-08 | ORDNANCE AND ACCESSORIES. Ligand Pharmaceuticals Acquires Apeiron Biologics AG for $100M | 2024-07-08 |. Market Inference combines deep investment …
Market Inference: Viewpoints
WEBMarket Inference combines deep investment knowledge, big data, and state of the art machine learning tools to create institutional quality stock reporting and investment analysis.
Market Inference: Financial Services
WEBMarket Inference combines deep investment knowledge, big data, and state of the art machine learning tools to create institutional quality stock reporting and investment analysis.
Graham: Your AI Equity Research Assistant
WEBUse AI to get the most recent financials from EDGAR and find unique investment opportunities. The equity research team at Market Inference joined forces with the industry leading AI innovators from Informatism, LLC to create a chatbot that can access, interpret, and report stock data. Just log in and start talking!
Unraveling the INTC Stock Surge - Market Inference
WEBJun 30, 2024 · Analysts have set target prices ranging from $17.0 to $58.53 per share for Intel, and have given the stock an average rating of hold. The stock has an average amount of shares sold short at 2.8%, and a short ratio of 1.51. At 0.06%, the company's rate of insider ownership does not indicate that management is heavily invested in the corporation.
Graham
WEBSign in with email. Forgot your password?
CarMax Reports Strong Q2 Results - Market Inference
WEB5 days ago · CarMax, Inc. (NYSE:KMX) has reported its second quarter fiscal year 2025 results, showing positive retail used unit growth and double-digit earnings increase. In the second quarter ended August 31, 2024, CarMax saw a 5.1% increase in retail used unit sales and a 4.3% increase in comparable store used unit sales compared to the prior year.
Daily Stock Reports - Market Inference
WEBAll Access Articles | CHEMICALS. Olin Lifts Force Majeure on Chlor-Alkali Products | 2024-08-28 | CHEMICALS ; Celanese 10-Q report shows 5% decrease in net sales | 2024-08-03 | CHEMICALS ; AdvanSix 10-Q Report Highlights Financials | 2024-08-03 | CHEMICALS ; Essential Information for DuPont de Nemours (DD) Investors | 2024-08-01 | CHEMICALS